​​​Updates made to coverage regarding specific techniques for Uterine Fibroid Myolysis​

June 6, 2022

​Independence is updating our position on laparoscopic (i.e., Acessa®) and transcervical (i.e., Sonata®) radiofrequency ablation from Experimental/Investigational to Medically Necessary for Independence and Independence Administrators members.

For detailed information, please refer to these new policies, effective June 6, 2022: